Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
03 06 2021
Historique:
received: 11 02 2021
accepted: 20 05 2021
entrez: 4 6 2021
pubmed: 5 6 2021
medline: 3 11 2021
Statut: epublish

Résumé

Sleep duration is a novel and potentially modifiable risk factor for cancer. We evaluated the association of self-reported sleep duration and daytime napping with odds of colorectal and gastric cancer. We included 2008 incident colorectal cancer cases, 542 gastric cancer cases and 3622 frequency-matched population controls, recruited in the MCC-Spain case-control study (2008-2013). Sleep information, socio-demographic and lifestyle characteristics were obtained through personal interviews. Multivariable adjusted logistic regression models were used to estimate odds ratios (OR) with 95% confidence intervals (CI) for cancer, across categories of sleep duration (≤ 5, 6, 7, 8, ≥ 9 hours/day), daytime napping frequency (naps/week) and duration (minutes/nap). Compared to 7 hours of sleep, long sleep was associated with increased odds of colorectal (OR

Identifiants

pubmed: 34083698
doi: 10.1038/s41598-021-91275-3
pii: 10.1038/s41598-021-91275-3
pmc: PMC8175745
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11822

Références

Sleep. 1983;6(3):179-85
pubmed: 6684786
Obes Rev. 2017 Feb;18 Suppl 1:15-24
pubmed: 28164449
Sleep. 2006 Jul;29(7):881-9
pubmed: 16895254
Sleep Med Rev. 2013 Feb;17(1):41-54
pubmed: 22560640
Chronobiol Int. 2021 Jun;38(6):893-906
pubmed: 33757396
Br J Cancer. 2013 Jan 15;108(1):213-21
pubmed: 23287986
Occup Environ Med. 2016 Aug;73(8):520-7
pubmed: 27312400
Sleep Med Rev. 2009 Aug;13(4):257-64
pubmed: 19095474
BMC Cancer. 2018 Nov 21;18(1):1149
pubmed: 30463535
J Epidemiol. 2012;22(5):462-8
pubmed: 22850546
Sleep Med Rev. 2007 Oct;11(5):341-60
pubmed: 17625932
Sleep. 2021 Feb 12;44(2):
pubmed: 32886784
Gac Sanit. 2015 Jul-Aug;29(4):308-15
pubmed: 25613680
Cancer Causes Control. 2012 Sep;23(9):1399-403
pubmed: 22806258
BMJ Open. 2016 Feb 17;6(2):e008119
pubmed: 26888725
PLoS One. 2016 Sep 09;11(9):e0161561
pubmed: 27611440
Sleep Med Rev. 2017 Aug;34:3-9
pubmed: 27568341
J Natl Cancer Inst. 2017 Aug 1;109(8):
pubmed: 28376186
BMJ. 2016 Nov 1;355:i5210
pubmed: 27803010
Ann N Y Acad Sci. 2010 Apr;1193:48-59
pubmed: 20398008
Chronobiol Int. 2016;33(4):325-50
pubmed: 27003385
Lancet. 2019 Oct 19;394(10207):1467-1480
pubmed: 31631858
Sleep Med Rev. 2004 Jun;8(3):159-74
pubmed: 15144959
Cancer Causes Control. 2019 May;30(5):501-525
pubmed: 30903483
Int J Mol Sci. 2017 Apr 17;18(4):
pubmed: 28420185
Sleep Health. 2017 Oct;3(5):383-388
pubmed: 28923198
Ann N Y Acad Sci. 2001 Mar;933:222-34
pubmed: 12000023
Sleep. 2013 May 01;36(5):681-8
pubmed: 23633750
Sleep. 2000 Mar 15;23(2):155-63
pubmed: 10737332
Scand J Work Environ Health. 2017 May 1;43(3):250-259
pubmed: 28251241
Biol Psychiatry. 2000 May 15;47(10):921-7
pubmed: 10807965
Ann Med. 2016 Dec;48(8):641-651
pubmed: 27558895
JCI Insight. 2020 Jan 16;5(1):
pubmed: 31941836
Am J Epidemiol. 2008 Dec 15;168(12):1353-64
pubmed: 18945686
Int J Cancer. 2014 Mar 1;134(5):1166-73
pubmed: 24037973
J Sleep Med Disord. 2014 Aug 28;1(1):
pubmed: 25374963
PLoS One. 2013 Aug 16;8(8):e71107
pubmed: 23976988
Nature. 1972 Jul 28;238(5361):226-7
pubmed: 4558354
Sleep Med. 2015 Apr;16(4):462-8
pubmed: 25794454
Int J Endocrinol. 2015;2015:591729
pubmed: 25861266
Am J Epidemiol. 2013 Sep 15;178(6):956-61
pubmed: 23801012
Nat Rev Gastroenterol Hepatol. 2019 Nov;16(11):690-704
pubmed: 31554963
J Clin Endocrinol Metab. 2003 Jan;88(1):26-30
pubmed: 12519823
Int J Cancer. 2021 Feb 15;148(4):914-920
pubmed: 32895918
Asian Pac J Cancer Prev. 2013;14(12):7509-15
pubmed: 24460326
Sleep. 2010 May;33(5):585-92
pubmed: 20469800
Epidemiology. 2008 Nov;19(6):838-45
pubmed: 18854708
Soc Sci Med. 2013 Feb;79:7-15
pubmed: 22682665
Scand J Work Environ Health. 2020 Nov 1;46(6):557-569
pubmed: 32895725
Eur Heart J. 2011 Jun;32(12):1484-92
pubmed: 21300732
J Sleep Res. 2009 Jun;18(2):148-58
pubmed: 19645960
Cancer Causes Control. 2015 Jul;26(7):1037-45
pubmed: 25924583
Int J Obes (Lond). 2008 Dec;32(12):1825-34
pubmed: 18936766
Sleep. 2017 Apr 1;40(4):
pubmed: 28329353
Sleep Med Rev. 2015 Oct;23:10-9
pubmed: 25645126
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Sleep Res. 2006 Sep;15(3):276-90
pubmed: 16911030
Cancer Epidemiol. 2020 Aug;67:101729
pubmed: 32464498
Semin Oncol. 2002 Jun;29(3 Suppl 7):5-11
pubmed: 12068382
J Epidemiol. 2012;22(3):244-50
pubmed: 22343331
Obesity (Silver Spring). 2015 Dec;23(12):2491-8
pubmed: 26727118
Diabetes Care. 2015 Mar;38(3):529-37
pubmed: 25715415
Curr Cardiol Rep. 2017 Sep 19;19(11):110
pubmed: 28929340
Nat Rev Immunol. 2019 Nov;19(11):702-715
pubmed: 31289370
J Sleep Res. 1999 Sep;8(3):175-83
pubmed: 10476003
Ergonomics. 1992 Dec;35(12):1453-63; discussion 1465-6
pubmed: 1490439

Auteurs

Kyriaki Papantoniou (K)

Department of Epidemiology, Center of Public Health, Medical University of Vienna, Kinderspitalgasse 15, 1090, Vienna, Austria. kyriaki.papantoniou@meduniwien.ac.at.
ISGlobal, Barcelona, Spain. kyriaki.papantoniou@meduniwien.ac.at.

Gemma Castaño-Vinyals (G)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Ana Espinosa (A)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Michelle C Turner (MC)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, ON, Canada.

Vicente Martín-Sánchez (V)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Biomedicine Institute (IBIOMED), University of León, Leon, Spain.

Delphine Casabonne (D)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Unit of Molecular and Genetic Epidemiology in Infections and Cancer (UNIC-Molecular), Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain.

Nuria Aragonés (N)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Epidemiology Section, Public Health Division, Department of Health of Madrid, Madrid, Spain.

Inés Gómez-Acebo (I)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
University of Cantabria, Santander, Spain.
IDIVAL, Santander, Spain.

Eva Ardanaz (E)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.

Jose-Juan Jimenez-Moleon (JJ)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
Instituto de Investigacion Biosanitaria de Granada (Ibs.GRANADA), Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

Pilar Amiano (P)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Public Health Division of Gipuzkoa, San Sebastian, Spain.
Biodonostia Research Institute, San Sebastian, Spain.

Ana Molina-Barceló (A)

Cancer and Public Health Area, FISABIO-Public Health, Valencia, Spain.

Juan Alguacil (J)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Centro de Investigación en Salud y Medio Ambiente (CYSMA), Universidad de Huelva, Campus Universitario de El Carmen, Huelva, Spain.

Guillermo Fernández-Tardón (G)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Health Research Institute of the Principality of Asturias, University of Oviedo, Oviedo, Spain.

José María Huerta (JM)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.

Natalia Hernández-Segura (N)

Biomedicine Institute (IBIOMED), University of León, Leon, Spain.

Beatriz Perez-Gomez (B)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Cancer Epidemiology Unit of the National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain.
Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain.

Javier Llorca (J)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
University of Cantabria, Santander, Spain.

Juana Vidán-Alli (J)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.

Rocıo Olmedo-Requena (R)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
Instituto de Investigacion Biosanitaria de Granada (Ibs.GRANADA), Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

Leire Gil (L)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Public Health Division of Gipuzkoa, San Sebastian, Spain.
Biodonostia Research Institute, San Sebastian, Spain.

Carmen Castañon-López (C)

Servicio de Oncología, Complejo Asistencial Universitario de León, Leon, Spain.

Marina Pollan (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Cancer Epidemiology Unit of the National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain.

Manolis Kogevinas (M)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Victor Moreno (V)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), Hospitalet de Llobregat, Barcelona, Spain.
Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain.
Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH